title: FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies.
authors.affiliation: Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.|Van Creveldkliniek, University Medical Centre Utrecht, Utrecht, The Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Fischer
authors.affiliation: Department of Clinical Epidemiology and Biostatistics, McMaster University, Toronto, ON, Canada.
authors.forename: A
authors.identifier: http://orcid.org/0000-0002-3331-8766
authors.initials: A
authors.lastname: Iorio
authors.affiliation: Medical Data Solutions and Services Ltd, Manchester, UK.
authors.forename: R
authors.initials: R
authors.lastname: Hollingsworth
authors.affiliation: Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.|Sheffield Haemophilia and Thrombosis Centre, University of Sheffield, Sheffield, UK.
authors.forename: M
authors.initials: M
authors.lastname: Makris
mesh_terms: D062313:Databases, Pharmaceutical; D055808:Drug Discovery; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D012042:Registries; D012449:Safety
chemical_list: D005169:Factor VIII